PhRMA Will Pursue Future ‘Cures’ Without Castellani: CEO Retiring Jan. 1
This article was originally published in The Pink Sheet Daily
John Castellani will step down at the end of the year as president and CEO of PhRMA after leading the association since September 2010.
You may also be interested in...
Long-time CEO of the Biotechnology Innovation Organization will remain until after the 2020 election and help with the leadership transition.
Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill and executing well-regarded public relations campaign of the kind the drug industry might need as it enters political maelstrom on pricing.
Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill, but also developing reputation of his own as a policy wonk.